BioSpace News Archive

Partnerships and programs address the social determinants of health across Indiana

Qventus, the leader in AI-based patient flow automation systems, today announced new Covid-19 custom planning products to help health systems forecast key resource needs both during and following the initial Covid-19 surge

As a key contributor to human health, drug-producing industries are expected to continue to operate at normal or near normal capacities despite the COVID-19 pandemic

Pangea Laboratory, LLC, a clinical testing facility in Orange County, announced its COVID-19 testing capacity of 1,000 samples per day.

InVivo Therapeutics Holdings Corp. (NVIV) today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules of 1,715,240 shares of its common stock at a purchase price of $1.75 per share

Kyyba Innovations LLC, a Michigan-based technical solutions corporation focused on solving global issues, has announced its weTrace app to help municipalities across the U.S. reduce the spread of COVID-19 by more quickly identifying those at risk and micro hot spots.

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced that it will present information on the edasalonexent program in Phase 3 development for the treatment of Duchenne muscular dystrophy (DMD) at the 2020 Muscular Dystrophy Association (MDA) Virtual Poster Session later this month. During the Virtual Poster Session, Catabasis and collaborators will present three poster

Biotech manufacturer recommended for continued certification to ISO 9001:2015 and ISO 13485:2016

Company Expects Full Loan Forgiveness Under Terms; Funds to be Used to Retain Workforce During Critical Spring Growing Season for U.S. Farmers

Today, COVID-19 testing startup Curative Inc. announced that the FDA has authorized its oral fluid test under Emergency Use Authorization (EUA) guidelines. T